APAC’s Premier CGT Congress - Uniting Leaders, Innovation, and Quality
#CGTAsia2026: driving breakthroughs in research, clinical applications, and manufacturing, while addressing Asia’s unique challenges.
As the region emerges as a global leader in regenerative medicine, Cell & Gene Therapy World Asia 2026 (#CGTAsia2026) returns as Asia’s most anticipated CGT knowledge-sharing conference for the 9th year! Designed to connect and empower stakeholders from the cell and gene therapy ecosystem, the event provides an unparalleled platform to explore the latest advancements in cell therapies, gene therapies, and CAR-T technologies.
Event Highlights:
- Hear from 50+ leading industry experts across Singapore, China, Japan, South Korea, Taiwan, and Australia as they share the latest advancements and future directions in cell and gene therapy, spanning CAR-T, TCR-T, gene editing, viral vectors, and next-generation CGT manufacturing platforms.
- Engage with 500+ senior-level decision-makers across biopharma, big pharma, CDMOs, academia, and technology providers to gain forward-looking insights into CGT development, clinical translation, manufacturing scale-up, and commercialization strategies in Asia.
- The Cell & Gene Therapy Excellence Awards 2026 celebrate breakthrough innovation, manufacturing leadership, and clinical progress across the CGT ecosystem in Asia-Pacific, recognising organisations advancing next-generation therapies.
- Co-located with RNA World Asia 2026 and Oligonucleotides & Peptides World Asia Congress 2026, the event enables cross-disciplinary networking across RNA, cell therapy, gene therapy, oligonucleotides, peptides, and biologics — bringing the full advanced therapeutics ecosystem together under one roof.
- Participate in a dedicated Poster Presentation Session showcasing cutting-edge CGT research, translational science, vector engineering, and early-stage innovations from leading academic institutes, biotech startups, and clinical research teams across Asia.
